What began as a specialized focus on TMS has evolved into an integrated ecosystem combining psychiatry, talk therapy, and ongoing patient support. When the practice launched, TMS remained a niche intervention; today, it serves as a cornerstone for addressing treatment-resistant depression, anxious depression, and OCD. By centralizing these services, Salience attempts to bridge the fragmented care gaps that often plague the behavioral health sector.
Chief Growth Officer Katherine Kriske notes that while the million-treatment milestone is statistically significant, the primary success lies in the tangible outcomes for families served. Dr. Nancy Donachie, Chief Medical Officer, emphasizes that this model shifts the focus beyond minor symptom relief toward long-term remission. The practice now prioritizes data-backed interventions, allowing providers to adjust care plans immediately if a patient fails to progress, ensuring that patient safety and trust remain the primary metrics of their success.



Comments (0)
No comments yet. Be the first!